alternatives to glp-1 drugs GLP-TRIM - A Natural Alternative glp 1 equivalency chart Promising

Description

For comparison, the SURMOUNT-1 trial for tirzepatide showed an average of 20.9% weight loss at the highest dose over 72 weeks

If you are considering weight loss treatment, Klinic can prescribe Zepbound today with insurance and prior authorization handled for you and transition you to retatrutide when it becomes available

This is highlighted by its notably highest values across various statistical parameters, including an IC at 4.17 (IC025 3.98), an ROR at 20.13 (95% CI 19.2121.09), and an EBGM at 18.04 (EBGM05 17.35)

10.1007/s11481-024-10142-w 19 DruckerD

While surgery still delivers the most extreme weight loss, the convenience and scalability of injectables may shift patient and physician preferences over time